Carbapenems: Past, Present, and FuturePAPP-WALLACE, Krisztina M; ENDIMIANI, Andrea; TARACILA, Magdalena A et al.Antimicrobial agents and chemotherapy. 2011, Vol 55, Num 11, pp 4943-4960, issn 0066-4804, 18 p.Article

Carbapenem antibiotics for serious infectionsHAWKEY, Peter M; LIVERMORE, David M.BMJ (Overseas and retired doctors ed.). 2012, Vol 344, Num 7863, pp 43-47, issn 1759-2151, 5 p.Article

Comparative Antipneumococcal Activities of Sulopenem and Other DrugsKOSOWSKA-SHICK, Klaudia; EDNIE, Lois M; MCGHEE, Pamela et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 6, pp 2239-2247, issn 0066-4804, 9 p.Article

Carbapenem Resistance in Elizabethkingia meningoseptica Is Mediated by Metallo-β-Lactamase BlaBGONZALEZ, Lisandro J; VILA, Alejandro J.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 4, pp 1686-1692, issn 0066-4804, 7 p.Article

The new treatment paradigm and the role of carbapenemsMASTERTON, Robert G.International journal of antimicrobial agents (Print). 2009, Vol 33, Num 2, pp 105-110, issn 0924-8579, 6 p.Article

Efficacy of Intravenous Infusion of DoripenemRESTREPO, Marcos I.Clinical infectious diseases. 2009, Vol 49, issn 1058-4838, S17-S27, SUP1Article

An Ongoing National Intervention to Contain the Spread of Carbapenem-Resistant EnterobacteriaceaeSCHWABER, Mitchell J; CARMELI, Yehuda.Clinical infectious diseases. 2014, Vol 58, Num 5, pp 697-703, issn 1058-4838, 7 p.Article

DoripenemPATERSON, David L; DEPESTEL, Daryl D.Clinical infectious diseases. 2009, Vol 49, Num 2, pp 291-298, issn 1058-4838, 8 p.Article

Managing Transmission of Carbapenem-Resistant Enterobacteriaceae in Healthcare Settings: A View From the TrenchesPALMORE, Tara N; HENDERSON, David K.Clinical infectious diseases. 2013, Vol 57, Num 11, pp 1593-1599, issn 1058-4838, 7 p.Article

Juvenile toxicity study of faropenem medoxomil in beagle puppiesFAQI, Ali S; LANPHEAR, Chery; GILL, Stan et al.Reproductive toxicology (Elmsford, NY). 2010, Vol 30, Num 4, pp 619-624, issn 0890-6238, 6 p.Article

Safety of Intravenous Infusion of DoripenemREDMAN, Rebecca; FILE, Thomas M.Clinical infectious diseases. 2009, Vol 49, issn 1058-4838, S28-S35, SUP1Article

Mise au point sur le doripénème = Focus on doripenemRéanimation (Paris. 2001). 2009, Vol 18, issn 1624-0693, 22 p., SUP2Serial Issue

Carbapenem De-escalation Therapy in a Resource-Limited SettingAPISARNTHANARAK, Anucha; BHOOANUSAS, Nuntanij; YAPRASERT, Apiwat et al.Infection control and hospital epidemiology. 2013, Vol 34, Num 12, pp 1310-1313, issn 0899-823X, 4 p.Article

Impact of Derepressed AmpC β-Lactamase ACT-9 on the Clinical Efficacy of ErtapenemLEE, Yi-Tzu; CHEN, Te-Li; SIU, Leung-Kei et al.Antimicrobial agents and chemotherapy. 2011, Vol 55, Num 9, pp 4440-4442, issn 0066-4804, 3 p.Article

Influence of Continuous Venovenous Hemofiltration and Continuous Venovenous Hemodiafiltration on the Disposition of DoripenemCIRILLO, Iolanda; VACCARO, Nicole; BALIS, Dainius et al.Antimicrobial agents and chemotherapy. 2011, Vol 55, Num 3, pp 1187-1193, issn 0066-4804, 7 p.Article

Carbapenem-non-susceptible Enterobacteriaceae in Europe: conclusions from a meeting of national expertsGRUNDMANN, H; LIVERMORE, D. M; JARLIER, V et al.Euro surveillance. 2011, Num NOV, pp 21-33, issn 1025-496X, 13 p., NSArticle

New Delhi Metallo 1: Have Carbapenems Met Their Doom?DESHPANDE, Payal; SHETTY, Anjali; KAPADIA, Farhad et al.Clinical infectious diseases. 2010, Vol 51, Num 10, issn 1058-4838, p. 1222Article

Résistance aux carbapénèmes chez les bacilles à Gram négatif : RESISTANCE AUX ANTIBIOTIQUES: UN ENJEU INTERNATIONAL = Gram-negative bacteriae with resistance to carbapenems : ANTIBIOTIC RESISTANCE: A WORLD CONCERNNORDMANN, Patrice.MS. Médecine sciences. 2010, Vol 26, Num 11, pp 950-959, issn 0767-0974, 10 p.Article

Acinetobacter radioresistens as a Silent Source of Carbapenem Resistance for Acinetobacter sppPOIREL, Laurent; FIGUEIREDO, Samy; CATTOIR, Vincent et al.Antimicrobial agents and chemotherapy. 2008, Vol 52, Num 4, pp 1252-1256, issn 0066-4804, 5 p.Article

Effect of Impaired Renal Function on the Pharmacokinetics of Tomopenem (R04908463/CS-023), a Novel CarbapenemMALLALIEU, Navita L; LENNON, Sian; MEI LIU et al.Antimicrobial agents and chemotherapy. 2008, Vol 52, Num 7, pp 2360-2366, issn 0066-4804, 7 p.Article

New developments in carbapenemsKATTAN, J. N; VILLEGAS, M. V; QUINN, J. P et al.Clinical microbiology and infection. 2008, Vol 14, Num 12, pp 1102-1111, issn 1198-743X, 10 p.Article

Biochemical Characterization of SFC-1, a Class A Carbapenem-Hydrolyzing β-LactamaseFONSECA, Fatima; SARMENTO, Ana Cristina; HENRIQUES, Isabel et al.Antimicrobial agents and chemotherapy. 2007, Vol 51, Num 12, pp 4512-4514, issn 0066-4804, 3 p.Article

No NDM-1 carriage in healthy persons from Mumbai: reassuring for nowDESHPANDE, Payal; VADWAI, Viral; SHETTY, Anjali et al.Journal of antimicrobial chemotherapy (Print). 2012, Vol 67, Num 4, pp 1046-1047, issn 0305-7453, 2 p.Article

Laboratory evaluation of the ESwab transport system for the recovery of carbapenem-resistant Acinetobacter baumanniiMORAN-GILAD, J; SCHWARTZ, D; NAVON-VENEZIA, S et al.European journal of clinical microbiology & infectious diseases (Print). 2012, Vol 31, Num 7, pp 1429-1433, issn 0934-9723, 5 p.Article

Clinical Carbapenem-Resistant Acinetobacter baylyi Strain Coharboring blaSIM-1 and blaOXA-23 from ChinaZHIHUI ZHOU; XIAOXING DU; LI WANG et al.Antimicrobial agents and chemotherapy. 2011, Vol 55, Num 11, pp 5347-5349, issn 0066-4804, 3 p.Article